Serum markers of brain-cell damage and C-reactive protein are unaffected by electroconvulsive therapy

References

• Agelink MW, Andrich J, Postert T, et al. Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100. J Neurol Neurosurg Psychiatry 2001; 71: 394–396
   PubMed Web of Science ®Google Scholar
• Berrouschot J, Rolle K, Kuhn HJ, Schneider D. Serum neuron-specific enolase levels do not increase after electroconvulsive therapy. J Neurol Sci 1997; 150: 173–176
   PubMed Web of Science ®Google Scholar
• Braasch ER, Demaso DR. Effect of electroconvulsive therapy on serum isoenzymes. Am J Psychiatry 1980; 137: 625–626
   PubMedGoogle Scholar
• Coffey CE, Weiner RD, Djang WT, et al. Brain anatomic effects of electroconvulsive therapy. A prospective magnetic resonance imaging study. Arch Gen Psychiatry 1991; 48: 1013–1021
   PubMedGoogle Scholar
• Dec GW, Jr, Stern TA, Welch C. The effects of electroconvulsive therapy on serial electrocardiograms and serum cardiac enzyme values. A prospective study of depressed hospitalized inpatients. J Am Med Assoc 1985; 253: 2525–2529
   PubMed Web of Science ®Google Scholar
• Devanand DP, Dwork AJ, Hutchinson ER, Bolwig TG, Sackeim HA. Does ECT alter brain structure?. Am J Psychiatry 1994; 151: 957–970
   PubMed Web of Science ®Google Scholar
• Greffe J, Lemoine P, Lacroix C, et al. Increased serum levels of neuron-specific enolase in epileptic patients and after electroconvulsive therapy – a preliminary report. Clin Chim Acta 1996; 244: 199–208
   PubMedGoogle Scholar
• Helzberg JH, Spiro HM. “LFTs” test more than the liver. J Am Med Assoc 1986; 256: 3006–3007
   PubMed Web of Science ®Google Scholar
• Hoyle NR, Pratt RT, Thomas DG. Effect of electroconvulsive therapy on serum myelin basic protein immunoreactivity. Br Med J (Clin Res Ed) 1984; 288: 1110–1111
   PubMedGoogle Scholar
• Jacobs DS, Demott WR, Finley PR, Horvat RT, Kasten BLJ, Tilzer LL. Laboratory Test Handbook. Lexi-Comp Inc, Hudson, (Cleveland) 1994
   Google Scholar
• Lisanby SH, Devanand DP, Prudic J, et al. Prolactin response to electroconvulsive therapy: effects of electrode placement and stimulus dosage. Biol Psychiatry 1998; 43: 146–155
   PubMedGoogle Scholar
• Lott JA, Pappas TN, Stang JM, Pitts C, Knopp W. Electroconvulsive therapy does not change serum CK, LD, or LD isoenzymes. J Clin Psychiatry 1982; 43: 169–170
   PubMedGoogle Scholar
• Ohaeri JU, Hedo CC, Enyidah SN, Ogunniyi AO. Tissue injury-inducing potential of unmodified ECT: Serial measurement of acute phase reactants. Convuls Ther 1992; 8: 253–257
   PubMedGoogle Scholar
• Pelsers MM, Hanhoff T, Van der Voort D, et al. Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility. Clin Chem 2004; 50: 1568–1575
   PubMed Web of Science ®Google Scholar
• Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27: 24–31
   PubMed Web of Science ®Google Scholar
• Sackeim HA, Prudic J, Devanand DP, et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000; 57: 425–434
   PubMed Web of Science ®Google Scholar
• Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 201–217
   PubMed Web of Science ®Google Scholar
• Tew JD, Jr, Mulsant BH, Haskett RF, et al. Acute efficacy of ECT in the treatment of major depression in the old- old. Am J Psychiatry 1999; 156: 1865–1870
   PubMed Web of Science ®Google Scholar
• The UK ECT Review Group. 2003. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 361:799–808.
   PubMed Web of Science ®Google Scholar
• van Waarde JA, Stek ML. [Electroconvulsive therapy effective and safe in 55 patients aged 56 years and older with mood disorders and physical comorbidity]. Ned Tijdschr Geneeskd 2001; 145: 1693–1697
   PubMedGoogle Scholar
• Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993; 90: 1351–1357
   Google Scholar
• Webb MG, O'Donnell MP, Draper RJ, Horner B, Phillips JP. Brain-type creatine phosphokinase serum levels before and after ECT. Br J Psychiatry 1984; 144: 525–528
   PubMedGoogle Scholar
• Zachrisson OC, Balldin J, Ekman R, et al. No evident neuronal damage after electroconvulsive therapy. Psychiatry Res 2000; 96: 57–165
   Google Scholar